Medicare’s Weight Loss Drug Breakthrough | Raleigh News

Medicare’s making a bold move into the weight-loss drug space, covering Wegovy and Zepbound for just $50 a month starting July 1st through a new temporary program called the Medicare GLP-1 Bridge. But here’s the twist: that $50 doesn’t count toward your yearly out-of-pocket limit or deductible, leaving seniors—especially those on fixed incomes—spending money that doesn’t trigger Medicare’s safety net. Plus, extra help programs can’t cover the copay, meaning seniors pay more without gaining protection. Not everyone qualifies either: you need a specific BMI, certain health conditions like heart failure or kidney disease, and your doctor must prescribe it for weight loss—not for a covered condition. And pharmacies must submit claims to the Bridge program, not your regular Part D plan. It’s a big deal, but with major caveats. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/26f54464cff1b4bd